STAT3 and interstitial lung disease: Studies on STAT3 GOF mutation-associated ILD were comprehensively searched on PubMed up to December 31, 2024, using the search terms “STAT3,” “gain-of-function,” and “ILD.” We identified seven cases of STAT3 GOF-associated ILD treated using tocilizumab.